• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Kyowa Kirin Receives Partial Change Approval for ORKEDIA in Japan firstwordpharma
    December 22, 2019
    The approval is based on the result of the Phase 3 clinical trial that evaluates the efficacy of ORKEDIA for hypercalcemia in patients with parathyroid carcinoma or primary hyperparathyroidism who are unable to undergo parathyroidectomy or relapse after p

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service